Skip to content

Nuvalent, Inc. NUVL Related Party Revenue Share Liability

Related Party Revenue Share Liability at other companies

Cytokinetics logo
CytokineticsCYTK
$539.11M+13.2%
Arrowhead Research logo
Arrowhead ResearchARWR
$383.83M+9.0%
Moderna logo
ModernaMRNA
$1.27M+56.0%
Natera, Inc. logo
Natera, Inc.NTRA
$500K-64.3%
Elanco Animal Health Inc. logo
Elanco Animal Health Inc.ELAN
$309M
Cytokinetics logo
CytokineticsCYTK
$138.8M+4.3%

Other financials

Income statement

See full
Operating income-$119.4M-25.9%
Net income-$109.3M-29.2%
EPS (diluted)-$1.39-17.8%

Balance sheet

See full
Cash & equivalents$159.7M+32.2%
Total equity$1.2B+16.2%
Total assets$1.3B+20.4%

Cash flow

See full
Operating cash flow-$92.4M-68.5%

Valuation

See full
Market cap$9.77B+58.6%

Returns & leverage

See full
Return on equity-41.2%+7.5pp
Current ratio16.1×+1.7×

Where this comes from

Reported directly by Nuvalent, Inc. in its filing.

Tagged under the XBRL concept nuvl:RelatedPartyRevenueShareLiability.

The official record: Nuvalent, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nuvalent, Inc.'s related party revenue share liability.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Nuvalent, Inc.'s related party revenue share liability?
Nuvalent, Inc. (NUVL) reported related party revenue share liability of $75.73M in Q1 2026.
How has Nuvalent, Inc.'s related party revenue share liability changed year-over-year?
Nuvalent, Inc.'s related party revenue share liability increased by 291.0% year-over-year, from $19.37M to $75.73M.
What does related party revenue share liability mean?
A long-term debt obligation to pay a share of future revenue to a partner or related entity.
How do you interpret related party revenue share liability?
An increase indicates the recognition of future obligations tied to successful development milestones, while a decrease reflects payments made or adjustments to estimates.
How does related party revenue share liability compare across companies?
Common in biotech companies that rely on in-licensed technology or collaborative development models.